By Counterforce Health Team in Humira (adalimumab) —

How to Get Humira (Adalimumab) Covered by Blue Cross Blue Shield in Georgia: Complete Requirements Guide

Answer Box: Getting Humira Covered by BCBS Georgia

To get Humira (adalimumab) covered by Blue Cross Blue Shield in Georgia, you must complete prior authorization and typically try preferred biosimilars first (step therapy). Submit the PA form with clinical documentation showing diagnosis, failed treatments, and medical necessity. If denied, file an internal appeal within 180 days, then request external review with Georgia's Department of Insurance within 60 days of the final denial. Most approvals require CVS Specialty or another in-network specialty pharmacy for dispensing.

Table of Contents

  1. Who Should Use This Guide
  2. Member & Plan Basics
  3. Clinical Criteria Requirements
  4. Coding & Documentation
  5. Submission Process
  6. Specialty Pharmacy Requirements
  7. After Submission: Tracking Your Request
  8. Appeals Process for Georgia
  9. Common Denial Pitfalls & Solutions
  10. Quick Reference Checklist

Who Should Use This Guide

This guide is for Georgia residents with Blue Cross Blue Shield coverage who need Humira (adalimumab) for conditions like rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, or hidradenitis suppurativa. You'll also find this helpful if you're a healthcare provider submitting prior authorization requests or appealing denials.

Expected outcomes: With proper documentation and adherence to BCBS Georgia's requirements, most medically appropriate Humira requests are approved, though you may need to try biosimilars first. If initially denied, appeals have reasonable success rates when clinical necessity is well-documented.

Member & Plan Basics

Active Coverage Requirements

  • Verify coverage: Log into your BCBS Georgia member portal or call the number on your ID card to confirm your plan includes specialty pharmacy benefits
  • Plan types: Requirements apply to both commercial and Medicare Advantage plans, though specific forms may differ
  • Deductible impact: Humira typically costs $6,000-$7,000 per month; high-deductible plans require meeting your deductible before coverage begins

Authorization Framework

BCBS Georgia requires prior authorization for all adalimumab products including Humira and biosimilars. The authorization process involves:

  • Clinical review of medical necessity
  • Step therapy compliance (trying preferred alternatives first)
  • Ongoing monitoring and reauthorization (typically every 6-12 months)

Clinical Criteria Requirements

FDA-Approved Indications

Humira must be prescribed for an FDA-approved indication:

  • Rheumatoid arthritis (moderate to severe)
  • Psoriatic arthritis
  • Ankylosing spondylitis
  • Crohn's disease (moderate to severe)
  • Ulcerative colitis (moderate to severe)
  • Plaque psoriasis (moderate to severe)
  • Hidradenitis suppurativa (moderate to severe)
  • Uveitis (non-infectious intermediate, posterior, and panuveitis)

Step Therapy Requirements

Based on BCBS Georgia's 2024 policies, patients typically must try and fail:

For inflammatory arthritis:

  • Methotrexate (unless contraindicated)
  • At least one preferred adalimumab biosimilar (Amjevita, Cyltezo, or others on formulary)

For inflammatory bowel disease:

  • Conventional therapies (5-ASA compounds, corticosteroids, immunomodulators as appropriate)
  • One preferred biologic (often infliximab biosimilar)

Documentation of Medical Necessity

Your provider must document:

  • Diagnosis with ICD-10 codes: M05/M06 (RA), L40.50 (PsA), K50 (Crohn's), K51 (UC)
  • Disease severity: Activity scores, symptom impact, functional limitations
  • Prior treatment failures: Specific medications, doses, duration, and reasons for discontinuation
  • Contraindications: If step therapy agents cannot be used
  • Treatment goals: Expected outcomes and monitoring plan

Coding & Documentation

Required Medical Codes

Condition ICD-10 Code Notes
Rheumatoid arthritis M05.-, M06.- Specify seropositive vs. other
Psoriatic arthritis L40.50 Include joint involvement
Crohn's disease K50.- Specify location if known
Ulcerative colitis K51.- Include extent of disease
Plaque psoriasis L40.0 Document body surface area
Hidradenitis suppurativa L73.2 Include Hurley stage

HCPCS/Billing Information

  • Humira injections: J0135 (adalimumab injection)
  • NDC numbers: Required for specialty pharmacy billing
  • Units: Specify per manufacturer's dosing guidelines
  • Site of care: Self-administered (pharmacy benefit) vs. provider-administered (medical benefit)

Medical Necessity Letter Components

Your healthcare provider's letter should include:

  1. Patient identification: Name, DOB, insurance ID, diagnosis
  2. Clinical history: Symptom onset, progression, impact on daily activities
  3. Previous treatments:
    • Medication names, doses, duration of trial
    • Specific reasons for discontinuation (ineffective, intolerance, contraindication)
    • Laboratory results or imaging supporting inadequate response
  4. Rationale for Humira: Why this specific medication is necessary
  5. Treatment plan: Dosing schedule, monitoring parameters, expected outcomes
  6. Supporting evidence: Reference to clinical guidelines or FDA labeling

Submission Process

Required Forms and Portals

BCBS Georgia requires submission through their designated channels:

  • Provider portal: Available at Anthem provider website (verify current link with your plan)
  • Prior authorization forms: Download the most current version from your plan's provider portal
  • Fax submission: Available as backup, but portal submission is preferred

Critical Fields That Cause Rejections

Based on common denial patterns:

  • Incomplete diagnosis information: Must include specific ICD-10 codes
  • Missing prior therapy details: Vague statements like "failed multiple medications" are insufficient
  • Inadequate duration documentation: Must show adequate trial periods (typically 3+ months unless intolerance)
  • Missing laboratory results: TB screening, hepatitis B testing, complete blood count
  • Incorrect dosing: Must align with FDA-approved dosing for the indication

Submission Timeline

  • Standard review: 15 business days from complete submission
  • Expedited review: Available for urgent medical situations (72 hours)
  • Incomplete submissions: Additional 15 days from when missing information is provided

Specialty Pharmacy Requirements

In-Network Preferred Vendors

According to Anthem BCBS Georgia's specialty pharmacy network, approved vendors include:

  • CVS Specialty (most common)
  • BioPlus Specialty Pharmacy
  • CenterWell Pharmacy
  • Harness Health Pharmacy
  • MUSC Health Specialty Pharmacy Services

Transfer Process

  1. Prescription routing: Your provider sends the prescription directly to the specialty pharmacy
  2. Insurance verification: The pharmacy confirms coverage and copay
  3. Patient enrollment: Complete intake forms and coordinate delivery
  4. First shipment: Typically within 3-5 business days of approval
Important: Using out-of-network specialty pharmacies may result in no coverage, requiring you to pay the full medication cost.

After Submission: Tracking Your Request

Confirmation and Status Checks

  • Confirmation number: Save this from your portal submission
  • Status updates: Check every 3-5 business days through the member portal
  • Direct contact: Call the prior authorization department using the number on your member ID card

What to Record

Keep detailed records of:

  • Submission date and confirmation number
  • All communication with BCBS (dates, representative names, reference numbers)
  • Any additional information requested
  • Decision letters and approval/denial notices

Approval Management

Once approved:

  • Approval period: Typically 6-12 months
  • Reauthorization: Submit renewal 30-60 days before expiration
  • Dose changes: May require new prior authorization

Appeals Process for Georgia

Internal Appeal (First Level)

If your initial request is denied:

  • Timeline: File within 180 days of denial notice
  • Required documents: Original denial letter, additional clinical evidence, provider statement
  • Decision timeframe: 30 days for standard appeals, 72 hours for urgent appeals

External Review (Georgia Department of Insurance)

After internal appeal denial:

  • Critical deadline: 60 days from final internal appeal decision
  • How to file: Submit request through Georgia Department of Insurance Consumer Services
  • Cost: Free to consumers
  • Decision: Binding on the insurance company
  • Timeline: 30 business days for standard review, 72 hours for expedited

Required Documentation for Appeals

  • Complete medical records supporting necessity
  • Letters from treating physicians
  • Clinical guidelines supporting treatment choice
  • Evidence of failed alternative therapies
  • Any new medical information since the original request

Common Denial Pitfalls & Solutions

Denial Reason How to Fix Required Documentation
Step therapy not completed Document contraindications or previous failures to preferred alternatives Provider letter detailing specific medical reasons biosimilars cannot be used
Insufficient medical necessity Provide detailed clinical rationale and supporting evidence Disease activity scores, functional assessments, treatment goals
Missing safety screening Complete required laboratory tests TB screening results, hepatitis B panel, CBC with differential
Incorrect diagnosis coding Verify ICD-10 codes match FDA-approved indications Medical records clearly documenting diagnosis with appropriate codes
Inadequate prior therapy documentation Provide specific details of previous treatments Pharmacy records, provider notes showing medication names, doses, dates, outcomes

Prevention Strategies

  1. Use current forms: Download the latest prior authorization forms from BCBS Georgia's provider portal
  2. Complete documentation: Include all required clinical information in the initial submission
  3. Verify network status: Confirm your specialty pharmacy is in-network before prescription transfer
  4. Meet deadlines: Submit reauthorizations 30-60 days before expiration
  5. Maintain records: Keep copies of all submissions and correspondence

Quick Reference Checklist

Before You Start - Gather These Items:

  • Insurance card and member ID number
  • Complete list of previous medications tried (names, doses, dates, outcomes)
  • Recent laboratory results (TB screening, hepatitis B, CBC)
  • Provider contact information and NPI number
  • Diagnosis confirmation with ICD-10 codes
  • Current prescription for Humira with specific indication

Submission Checklist:

  • Complete prior authorization form (current version)
  • Medical necessity letter from provider
  • Clinical notes supporting diagnosis and severity
  • Documentation of failed step therapy (unless contraindicated)
  • Required laboratory screening results
  • Prescription sent to in-network specialty pharmacy
  • Confirmation number recorded

If Denied:

  • Review denial letter for specific reasons
  • Gather additional supporting documentation
  • File internal appeal within 180 days
  • If internal appeal fails, request Georgia DOI external review within 60 days
  • Keep detailed records of all communications

For patients navigating complex prior authorization requirements and appeals, Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with payer requirements, helping patients and providers get prescription drugs approved more efficiently.

From our advocates: "We've seen the best outcomes when patients work closely with their specialty pharmacy from day one. The pharmacy can often identify potential coverage issues before they become denials and help coordinate with the provider to submit complete documentation. Don't wait until after a denial to engage your specialty pharmacy team."

Frequently Asked Questions

How long does BCBS Georgia prior authorization take for Humira? Standard reviews take up to 15 business days from complete submission. Expedited reviews for urgent situations can be completed within 72 hours.

What if Humira is not on my plan's formulary? You can request a formulary exception by demonstrating medical necessity and providing clinical justification for why preferred alternatives are not appropriate.

Can I get an expedited appeal in Georgia? Yes, if your condition poses serious risk to your health. Both internal appeals and external reviews through Georgia's Department of Insurance offer expedited timelines for urgent situations.

Does step therapy apply if I've tried biosimilars outside of Georgia? Yes, previous therapy trials from other states count toward step therapy requirements, provided you have adequate documentation of the trials and outcomes.

How much will Humira cost with BCBS Georgia coverage? Costs vary by plan, but specialty medications typically have higher copays ($50-$200+) or coinsurance (20-40% after deductible). Check with your plan for specific cost-sharing details.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies and requirements can change. Always verify current requirements with your specific BCBS Georgia plan and consult with your healthcare provider regarding appropriate treatment options. For additional consumer assistance with insurance appeals in Georgia, contact the Georgia Department of Insurance Consumer Services at 1-800-656-2298.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.